why choose us

Clinical Trials Search

Showing 10,010 of 132,656 result(s)
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed;Refractory Cutaneous T-cell Lymphomas

Status: Completed

Condition: Cutaneous T Cell Lymphoma

Interventions: 400mg Intravenously

Date: 2023-07-13

Pediatric Percutaneous Ultrasound Gastrostomy Technique

Status: Completed

Condition: Gastrostomy

Interventions: Ultrasound guided placement of gastrostomy tube using the PUMA-G Pediatric System

Date: 2023-07-13

Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0

Status: Completed

Condition: Heart Failure

Interventions: Direct Sodium Removal via peritoneal ultrafiltration using Infusate 2.0 (30% icodextrin, 10% dextrose).
Patients (if not yet on SGLT-2 inhibitors

Date: 2023-07-13

Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient with Hepatic Involvement

Status: COMPLETED

Condition: Hereditary Hemorrhagic Telangiectasia

Interventions: After a rest trans thoracic echocardiography (usual follow-up), eligible patients will have a stress ultrasound echocardiography on a dedicated cycle

Date: 2023-07-13

Examining the Impact of a Mobile Nutrition Education App for Child Nutrition Education in Canada

Status: COMPLETED

Condition: Nutrition, Healthy

Interventions: Classrooms will receive nutrition education lessons for 35-40 minutes for 5 consecutive days.
As part of each lesson, students will play the &quo

Date: 2023-07-13

Alcohol & Exercise Study

Status: COMPLETED

Condition: Alcohol-Related Disorders

Interventions: 20 minutes of Moderate intensity (40%-59% heartrate reserve) walking on a treadmill.

Date: 2023-07-13

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

Status: COMPLETED

Condition: Atopic Dermatitis

Interventions: After a loading dose of 600 mg under the skin (s.c.) at baseline, trial participants are administered a dose of 300 mg every two weeks for 32 weeks

Date: 2023-07-13

A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

Status: COMPLETED

Condition: Antibiotic Toxicity

Interventions: There are no risks associated with participation because only waste material (blood and ascites) will be used for analysis and no additional blood col

Date: 2023-07-13

Efficacy of Ultrasound-guided Internal Jugular Vein Versus Supraclavicular Subclavian Vein Cannulation in Neonates and Infants Less Than 5 kg.

Status: COMPLETED

Condition: Pediatric

Interventions: receive ultrasound guided SCV cannulation

Date: 2023-07-13